Skip to main content

Peer Review reports

From: Screening antiproliferative drug for breast cancer from bisbenzylisoquinoline alkaloid tetrandrine and fangchinoline derivatives by targeting BLM helicase

Original Submission
3 Jul 2018 Submitted Original manuscript
10 Sep 2018 Reviewed Reviewer Report - Ankita Jaykumar
13 Sep 2018 Reviewed Reviewer Report - Rajan Chaudhari
24 Jul 2019 Author responded Author comments - Wangming Zhang
Resubmission - Version 2
24 Jul 2019 Submitted Manuscript version 2
4 Sep 2019 Author responded Author comments - Wangming Zhang
Resubmission - Version 3
4 Sep 2019 Submitted Manuscript version 3
9 Sep 2019 Author responded Author comments - Wangming Zhang
Resubmission - Version 4
9 Sep 2019 Submitted Manuscript version 4
Publishing
10 Sep 2019 Editorially accepted
28 Oct 2019 Article published 10.1186/s12885-019-6146-7

You can find further information about peer review here.

Back to article page